TCL Archive Sharp Increase In Cancer Mortality Could Bring Drastic Program Changes; All 1975 Data Needed December 12, 1975
TCL Archive Slow Accruing Trials Should Be Removed From High Priority Program, Broder Says October 2, 1992
TCL Archive Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial July 25, 2014
TCL Archive Highlights of NCDDGs: 3 Drugs on Market, 12 in Development; Advisors Approve Plan to Issue $10.5 Million Contract For Pediatric Preclinical Testing Program November 29, 2002
